This is a preview of subscription content, log in to check access.
Brighty K, Gootz T. The chemistry and biological profile of trovafloxacin. J Antimicrob Chemother 1997; Suppl. B, 39: 1–14PubMedCrossRefGoogle Scholar
Kaatz G, Seo S. Topoisomerase mutations in fluoroquinolone-resistant and methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 1998; 42: 197–8PubMedGoogle Scholar
Pan X-S, Fisher ML. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase intravenous by quinolones. Antimicrob Agents Chemother 1997; 41: 471–4PubMedGoogle Scholar